MedTrace Logo

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

NCT05428501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2024-09-19

No results posted yet for this study

Summary

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Conditions

Interventions

OTHER

no treatment given

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency (dept. 2834) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-18
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05428501 on ClinicalTrials.gov